176 related articles for article (PubMed ID: 17661084)
1. Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer.
Hudelist G; Wülfing P; Kersting C; Burger H; Mattsson B; Czerwenka K; Kubista E; Gschwantler-Kaulich D; Fink-Retter A; Singer CF
J Cancer Res Clin Oncol; 2008 Jan; 134(1):67-73. PubMed ID: 17661084
[TBL] [Abstract][Full Text] [Related]
2. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
Oliveira VM; Piato S; Silva MA
Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
[TBL] [Abstract][Full Text] [Related]
3. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
5. [Aromatase expression in invasive and in situ ductal carcinoma present in the same breast].
Oliveira VM; Ribeiro Lde S; Rossi LM; Silva MA; Aldrighi JM; Bagnoli F; Rinaldi JF; Aoki T
Rev Assoc Med Bras (1992); 2009; 55(6):651-5. PubMed ID: 20191218
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study.
Çiriş IM; Bozkurt KK; Başpinar S; Kapucuoğlu FN
Pathol Res Pract; 2011 Mar; 207(3):182-7. PubMed ID: 21371829
[TBL] [Abstract][Full Text] [Related]
7. Aromatase and in situ estrogen production in DCIS (ductal carcinoma in situ) of human breast.
Sasano H; Miki Y; Shibuya R; Suzuki T
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):242-5. PubMed ID: 19782135
[TBL] [Abstract][Full Text] [Related]
8. Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast.
Zhang Z; Yamashita H; Toyama T; Hara Y; Omoto Y; Sugiura H; Kobayashi S; Harada N; Iwase H
Breast Cancer Res Treat; 2002 Jul; 74(1):47-53. PubMed ID: 12150452
[TBL] [Abstract][Full Text] [Related]
9. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
10. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
12. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
[TBL] [Abstract][Full Text] [Related]
13. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters.
Jin JS; Cheng TF; Tsai WC; Sheu LF; Chiang H; Yu CP
Histol Histopathol; 2007 Mar; 22(3):305-9. PubMed ID: 17163404
[TBL] [Abstract][Full Text] [Related]
14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.
Pan H; Wu N; Huang Y; Li Q; Liu C; Liang M; Zhou W; Liu X; Wang S
Diagn Pathol; 2015 Jun; 10():66. PubMed ID: 26070788
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.
Toss M; Miligy I; Gorringe K; Mittal K; Aneja R; Ellis I; Green A; Rakha E
J Clin Pathol; 2020 Feb; 73(2):76-82. PubMed ID: 31444238
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast.
Aguiar FN; Mendes HN; Bacchi CE; Carvalho FM
Rev Bras Ginecol Obstet; 2013 Mar; 35(3):97-102. PubMed ID: 23538467
[TBL] [Abstract][Full Text] [Related]
18. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
19. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in ductal carcinoma in situ of the breast.
Shpitz B; Zimlichman S; Zemer R; Bomstein Y; Zehavi T; Liverant S; Bernehim J; Kaufman Z; Klein E; Shapira Y; Klein A
Breast Cancer Res Treat; 1999 Nov; 58(1):65-9. PubMed ID: 10634519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
